Skip to main content
SpringerPlus
Figure 1 | SpringerPlus

Figure 1

From: Predictive impact of polymorphism of PNPLA3 on HCC development after interferon therapy in Japanese patients with chronic hepatitis C

Figure 1

The incidence of HCC development after interferon therapy. The incidence of HCC development after interferon therapy was presumed by the Kaplan–Meier method for each group by dividing the patients by the outcomes of the interferon therapy (A), serum levels of alpha fetoproteins prior to the interferon therapy (B), and the SNP genotypes of PNPLA3 (C).

Back to article page